1. Takeda Pushes Back as Group Seeks to Stop $62 Billion Shire Deal

    Takeda Pushes Back as Group Seeks to Stop $62 Billion Shire Deal

    (Bloomberg) -- Takeda Pharmaceutical Co. Chief Executive Officer Christophe Weber pushed back against dissident shareholders seeking to stop the Japanese drugmaker’s acquisition of Shire Plc, saying he won’t release minutes of boardroom discussions. A group including members of Takeda’s founding family opposes the planned $62 billion acquisition of the U.K.-listed biotech firm, which would rank as the biggest overseas takeover by a Japanese company...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. We discuss many confidential topics, and we think board minutes should remain confidential.
    2. They have a different vision of what Takeda should become.
  3. Topics Mentioned

  4. Authors